PubMed:21325775 / 0-182 JSONTXT

{"project":"LitCoin-sentences","denotations":[{"id":"T1","span":{"begin":0,"end":118},"obj":"Sentence"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-entities","denotations":[{"id":"8534","span":{"begin":8,"end":24},"obj":"GeneOrGeneProduct"},{"id":"8535","span":{"begin":35,"end":39},"obj":"GeneOrGeneProduct"},{"id":"8536","span":{"begin":47,"end":57},"obj":"SequenceVariant"},{"id":"8537","span":{"begin":65,"end":77},"obj":"DiseaseOrPhenotypicFeature"},{"id":"8538","span":{"begin":78,"end":85},"obj":"OrganismTaxon"},{"id":"8539","span":{"begin":91,"end":117},"obj":"DiseaseOrPhenotypicFeature"},{"id":"8540","span":{"begin":119,"end":145},"obj":"DiseaseOrPhenotypicFeature"},{"id":"8541","span":{"begin":147,"end":150},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"db_id","subj":"8534","obj":"NCBIGene:348"},{"id":"A2","pred":"db_id","subj":"8535","obj":"NCBIGene:348"},{"id":"A3","pred":"db_id","subj":"8536","obj":"p|SUB|R|158|P"},{"id":"A4","pred":"db_id","subj":"8537","obj":"MESH:D050171"},{"id":"A5","pred":"db_id","subj":"8538","obj":"NCBITaxon:9606"},{"id":"A6","pred":"db_id","subj":"8539","obj":"MESH:C567089"},{"id":"A7","pred":"db_id","subj":"8540","obj":"MESH:C567089"},{"id":"A8","pred":"db_id","subj":"8541","obj":"MESH:C567089"}],"namespaces":[{"prefix":"_base","uri":"https://w3id.org/biolink/vocab/"},{"prefix":"MESH","uri":"http://id.nlm.nih.gov/mesh/"},{"prefix":"NCBITaxon","uri":"https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id="},{"prefix":"NCBIGene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"OMIM","uri":"https://www.omim.org/entry/"},{"prefix":"DBSNP","uri":"https://www.ncbi.nlm.nih.gov/snp/"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin_Mondo","denotations":[{"id":"T1","span":{"begin":91,"end":117},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":119,"end":145},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":157,"end":161},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0012725"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0012725"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0021136"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-SeqVar","denotations":[{"id":"T1","span":{"begin":47,"end":57},"obj":"SequenceVariant"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-GeneOrGeneProduct-v0","denotations":[{"id":"T1","span":{"begin":2,"end":7},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":8,"end":24},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":25,"end":33},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":35,"end":39},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":60,"end":64},"obj":"GeneOrGeneProduct"},{"id":"T6","span":{"begin":91,"end":102},"obj":"GeneOrGeneProduct"},{"id":"T7","span":{"begin":119,"end":130},"obj":"GeneOrGeneProduct"},{"id":"T8","span":{"begin":157,"end":161},"obj":"GeneOrGeneProduct"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-GeneOrGeneProduct-v2","denotations":[{"id":"T1","span":{"begin":2,"end":7},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":8,"end":24},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":91,"end":102},"obj":"GeneOrGeneProduct"},{"id":"T4","span":{"begin":119,"end":130},"obj":"GeneOrGeneProduct"},{"id":"T5","span":{"begin":157,"end":161},"obj":"GeneOrGeneProduct"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-Disease-MeSH","denotations":[{"id":"T1","span":{"begin":91,"end":117},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":119,"end":145},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":147,"end":150},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":157,"end":169},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"originalLabel","subj":"T1","obj":"C567089"},{"id":"A2","pred":"originalLabel","subj":"T2","obj":"C567089"},{"id":"A3","pred":"originalLabel","subj":"T3","obj":"C567089"},{"id":"A4","pred":"originalLabel","subj":"T4","obj":"D035583"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-GeneOrGeneProduct-v3","denotations":[{"id":"T1","span":{"begin":8,"end":24},"obj":"GeneOrGeneProduct"},{"id":"T2","span":{"begin":91,"end":102},"obj":"GeneOrGeneProduct"},{"id":"T3","span":{"begin":119,"end":130},"obj":"GeneOrGeneProduct"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin_Mondo_095","denotations":[{"id":"T1","span":{"begin":91,"end":117},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":119,"end":145},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":147,"end":150},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"0012725"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"0012725"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"0012725"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-MeSH-Disease-2","denotations":[{"id":"T1","span":{"begin":65,"end":77},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":91,"end":117},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":119,"end":145},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":147,"end":150},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T5","span":{"begin":157,"end":169},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"DISEASE"},{"id":"A2","pred":"ID:","subj":"T2","obj":"C567089"},{"id":"A3","pred":"ID:","subj":"T3","obj":"C567089"},{"id":"A4","pred":"ID:","subj":"T4","obj":"C567089"},{"id":"A5","pred":"ID:","subj":"T5","obj":"D035583"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-MONDO_bioort2019","denotations":[{"id":"T1","span":{"begin":65,"end":77},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T2","span":{"begin":91,"end":117},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T3","span":{"begin":119,"end":145},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T4","span":{"begin":147,"end":150},"obj":"DiseaseOrPhenotypicFeature"}],"attributes":[{"id":"A1","pred":"#label","subj":"T1","obj":"DISEASE"},{"id":"A2","pred":"#label","subj":"T2","obj":"C567089"},{"id":"A3","pred":"#label","subj":"T3","obj":"C567089"},{"id":"A4","pred":"#label","subj":"T4","obj":"C567089"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-Chemical-MeSH-CHEBI","denotations":[{"id":"T1","span":{"begin":8,"end":22},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":54,"end":57},"obj":"ChemicalEntity"},{"id":"T3","span":{"begin":147,"end":150},"obj":"ChemicalEntity"}],"attributes":[{"id":"A1","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_39015"},{"id":"A2","pred":"ID:","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50342"},{"id":"A3","pred":"ID:","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_59681"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-NCBITaxon-2","denotations":[{"id":"T1","span":{"begin":78,"end":85},"obj":"OrganismTaxon"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"LitCoin-training-merged","denotations":[{"id":"T3","span":{"begin":147,"end":150},"obj":"ChemicalEntity"},{"id":"T2","span":{"begin":54,"end":57},"obj":"ChemicalEntity"},{"id":"T1","span":{"begin":8,"end":22},"obj":"ChemicalEntity"},{"id":"T86738","span":{"begin":119,"end":130},"obj":"GeneOrGeneProduct"},{"id":"T85608","span":{"begin":91,"end":102},"obj":"GeneOrGeneProduct"},{"id":"T9920","span":{"begin":8,"end":24},"obj":"GeneOrGeneProduct"},{"id":"T91188","span":{"begin":147,"end":150},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T65387","span":{"begin":119,"end":145},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T19616","span":{"begin":91,"end":117},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T53256","span":{"begin":65,"end":77},"obj":"DiseaseOrPhenotypicFeature"},{"id":"T69208","span":{"begin":78,"end":85},"obj":"OrganismTaxon"},{"id":"T38839","span":{"begin":47,"end":57},"obj":"SequenceVariant"}],"attributes":[{"id":"A3","pred":"ID:","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_59681"},{"id":"A2","pred":"ID:","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_50342"},{"id":"A1","pred":"ID:","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_39015"},{"id":"A7843","pred":"#label","subj":"T91188","obj":"C567089"},{"id":"A22044","pred":"#label","subj":"T65387","obj":"C567089"},{"id":"A95776","pred":"#label","subj":"T19616","obj":"C567089"},{"id":"A97349","pred":"#label","subj":"T53256","obj":"DISEASE"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":118},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":118},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"DisGeNET","denotations":[{"id":"T0","span":{"begin":8,"end":24},"obj":"gene:348"},{"id":"T1","span":{"begin":91,"end":117},"obj":"disease:C2673196"},{"id":"T3","span":{"begin":119,"end":145},"obj":"disease:C2673196"},{"id":"T5","span":{"begin":157,"end":169},"obj":"disease:C0678236"},{"id":"T7","span":{"begin":147,"end":150},"obj":"disease:C2673196"},{"id":"T9","span":{"begin":119,"end":145},"obj":"disease:C2673196"},{"id":"T11","span":{"begin":157,"end":169},"obj":"disease:C0678236"},{"id":"T13","span":{"begin":147,"end":150},"obj":"disease:C2673196"}],"relations":[{"id":"R1","pred":"associated_with","subj":"T0","obj":"T1"}],"namespaces":[{"prefix":"gene","uri":"http://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"disease","uri":"http://purl.bioontology.org/ontology/MEDLINEPLUS/"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":131,"end":145},"obj":"HP_0100820"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"Allie","denotations":[{"id":"SS1_21325775_1_0","span":{"begin":119,"end":145},"obj":"expanded"},{"id":"SS2_21325775_1_0","span":{"begin":147,"end":150},"obj":"abbr"}],"relations":[{"id":"AE1_21325775_1_0","pred":"abbreviatedTo","subj":"SS1_21325775_1_0","obj":"SS2_21325775_1_0"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"21325775-0#8#24#gene348","span":{"begin":8,"end":24},"obj":"gene348"},{"id":"21325775-0#91#117#diseaseC2673196","span":{"begin":91,"end":117},"obj":"diseaseC2673196"}],"relations":[{"id":"8#24#gene34891#117#diseaseC2673196","pred":"associated_with","subj":"21325775-0#8#24#gene348","obj":"21325775-0#91#117#diseaseC2673196"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"PubCasesHPO","denotations":[{"id":"AB1","span":{"begin":131,"end":145},"obj":"HP:0100820"},{"id":"TI1","span":{"begin":103,"end":117},"obj":"HP:0100820"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"PubCasesORDO","denotations":[{"id":"AB1","span":{"begin":119,"end":145},"obj":"ORDO:329481"},{"id":"AB2","span":{"begin":147,"end":150},"obj":"ORDO:329481"},{"id":"TI1","span":{"begin":91,"end":117},"obj":"ORDO:329481"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}

{"project":"tmVarCorpus","denotations":[{"id":"T1","span":{"begin":47,"end":57},"obj":"ProteinMutation:p|SUB|R|158|P"}],"text":"A novel apolipoprotein E mutation, ApoE Osaka (Arg158 Pro), in a dyslipidemic patient with lipoprotein glomerulopathy.\nLipoprotein glomerulopathy (LPG) is a rare disease characterize"}